Apocynin (4-hydroxy-3-methoxyacetophenone) inhibits NADPH oxidase activity by interfering with the membrane translocation of p47phox and p67phox and has been used extensively as a Nox inhibitor in stroke studies. Here, FMO5 is linked to stroke disorder.